MD
Mark E Delaney (SVP & Chief Commercial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Quest Diagnostics Incorporated (DGX). The largest single filing was $1.5M of DGX (7,946 sh × $187.35, as filed), executed Nov 18 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$376K
shares × price, as filed
Last traded
Jul 28
Filed Jul 29
Median ADV $221.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
DGXRecent filings
DGXSALE
Quest Diagnostics Incorporated
View filing →
$376K1,600 sh × $235.18
Exec Jul 28
Filed Jul 29 · 5:04 PM ET DGXSALE Quest Diagnostics Incorporated View filing → $1.5M
7,946 sh × $187.35
Exec Nov 18 2025
Filed Nov 20 2025 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated View filing → $307K
1,748 sh across 2 lots
Exec May 12 2025
Filed May 14 2025 · 5:30 PM ET